Liposomal doxorubicin in AIDS-related Kaposi's sarcoma

Lancet. 1993 Aug 21;342(8869):497. doi: 10.1016/0140-6736(93)91624-u.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Adult
  • Bone Marrow / drug effects
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Doxorubicin / therapeutic use*
  • Drug Tolerance
  • Humans
  • Liposomes
  • Neutropenia / chemically induced
  • Remission Induction
  • Risk Factors
  • Sarcoma, Kaposi / drug therapy*
  • Sarcoma, Kaposi / etiology*
  • Survival Rate

Substances

  • Liposomes
  • Doxorubicin